Patents by Inventor Andrew Harrison

Andrew Harrison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyridinone dicarboxamide for use as bromodomain inhibitors
    Patent number: 10927080
    Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy
    Type: Grant
    Filed: August 8, 2019
    Date of Patent: February 23, 2021
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    Inventors: Stephen John Atkinson, Helen Elizabeth Aylott, Anthony William James Cooper, Emmanuel Hubert Demont, Lee Andrew Harrison, Thomas George Christopher Hayhow, Matthew J. Lindon, Alexander G. Preston, Jonathan Thomas Seal, Ian David Wall, Robert J. Watson, James Michael Woolven
  • 2,3-DISUBSTITUTED 1-ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS
    Publication number: 20210046073
    Abstract: The present invention relates to novel compounds, pharmaceutical compositions containing such compounds and to their use in therapy.
    Type: Application
    Filed: January 7, 2020
    Publication date: February 18, 2021
    Inventors: Dominique Amans, Stephen John Atkinson, Lee Andrew Harrison, David Jonathan Hirst, Robert Peter Law, Matthew Lindon, Alexander Preston, Jonathan Thomas Seal, Christopher Roland Wellaway
  • Pyridyl derivatives as bromodomain inhibitors
    Patent number: 10849897
    Abstract: The present invention is directed to pyridyl derivatives which are bromodomain inhibitors, pharmaceutical compositions comprising the compounds and the use of the compounds or the compositions in the treatment of various diseases or conditions.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: December 1, 2020
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    Inventors: Stephen John Atkinson, Emmanuel Hubert Demont, Lee Andrew Harrison, Etienne Levernier, Alexander G. Preston, Jonathan Thomas Seal, Ian David Wall, Robert J. Watson, James Michael Woolven
  • Pyridine dicarboxamide derivatives as bromodomain inhibitors
    Patent number: 10844015
    Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.
    Type: Grant
    Filed: May 22, 2017
    Date of Patent: November 24, 2020
    Assignee: GlaxoSmithKline Intellectual Property (No. 2) Limited
    Inventors: Stephen John Atkinson, Emmanuel Hubert Demont, Lee Andrew Harrison, Etienne Levernier, Alexander G. Preston, Jonathan Thomas Seal, Ian David Wall, Robert J. Watson, James Michael Woolven
  • 2,3-DIHYDROBENZOFURANS AS BROMODOMAIN INHIBITORS
    Publication number: 20200291009
    Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.
    Type: Application
    Filed: October 4, 2018
    Publication date: September 17, 2020
    Inventors: Stephen John ATKINSON, Emmanuel Hubert DEMONT, Lee Andrew HARRISON, Simon Christopher Cranko LUCAS, Alexander G. PRESTON, Jonathan Thomas SEAL, Ian David WALL, Robert J. WATSON, James Michael WOOLVEN
  • BENZOFURAN DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS
    Publication number: 20200289464
    Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.
    Type: Application
    Filed: October 4, 2018
    Publication date: September 17, 2020
    Inventors: Stephen John ATKINSON, Emmanuel Hubert DEMONT, Lee Andrew HARRISON, Simon Christopher Cranko LUCAS, Alexander G. PRESTON, Jonathan Thomas SEAL, Ian David WALL, Robert J. WATSON, James Michael WOOLVEN
  • Methods and Apparatus for Event Management
    Publication number: 20200210400
    Abstract: Apparatus and methods are provided for enabling a sensor device to receive and transmit updates effectively via one or more rules applied to a plurality of event records for transmission by an event management server. In one exemplary embodiment, the event management server manages the plurality of event records (such as records of deletions or updates to a user's profile or goals), via an event suppression application. The event suppression application ensures that event records are not redundantly provided to the sensor device and/or irrelevant records (such as those which no longer contain the most up-to-date information) are not provided to the sensor device. Hence, only the most relevant event records are provided and that those which are not relevant are ignored (not transmitted). In this manner, the sensor device may operate more efficiently to receive only the most relevant transmissions.
    Type: Application
    Filed: March 11, 2020
    Publication date: July 2, 2020
    Inventors: Nicholas Villalva, Bradford J. Fults, Andrew Harrison, Ben Hamill, Carlos Rivera
  • Methods and apparatus for event management
    Patent number: 10606819
    Abstract: Apparatus and methods are provided for enabling a sensor device to receive and transmit updates effectively via one or more rules applied to a plurality of event records for transmission by an event management server. In one exemplary embodiment, the event management server manages the plurality of event records (such as records of deletions or updates to a user's profile or goals), via an event suppression application. The event suppression application ensures that event records are not redundantly provided to the sensor device and/or irrelevant records (such as those which no longer contain the most up-to-date information) are not provided to the sensor device. Hence, only the most relevant event records are provided and that those which are not relevant are ignored (not transmitted). In this manner, the sensor device may operate more efficiently to receive only the most relevant transmissions.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: March 31, 2020
    Assignee: Under Armour, Inc.
    Inventors: Nicholas Villalva, Bradford J. Fults, Andrew Harrison, Ben Hamill, Carlos Rivera
  • POWER GENERATING APPARATUS
    Publication number: 20200088157
    Abstract: Disclosed herein is a power generating apparatus for extracting energy from flowing water. The apparatus comprises a buoyancy vessel, and a turbine assembly coupled to the buoyancy vessel which comprises a turbine rotor mounted to a nacelle, and a support structure. The turbine assembly is pivotally moveable between a first position and a second position. When the power generating apparatus is floating on a body of water, in the first position the nacelle is fully submerged below the water surface; and in the second position at least a part of the nacelle projects above the water surface. Movement of the turbine assembly from the first position to the second position is buoyancy assisted, for example by providing the turbine assembly with positive buoyancy or selectively increasing its buoyancy.
    Type: Application
    Filed: November 6, 2017
    Publication date: March 19, 2020
    Applicant: Orbital Marine Power Limited
    Inventors: Jonathan Meason, Calum Millar, William Annal, Andrew Harrison, Axel Bondoux, Ross McKay Henderson, Carn Nathaniel George Gibson, Charles Andrew Edward Taylor, Jonathan Ian Benzie
  • 2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
    Patent number: 10583139
    Abstract: The present invention relates to novel compounds, pharmaceutical compositions containing such compounds and to their use in therapy.
    Type: Grant
    Filed: June 25, 2018
    Date of Patent: March 10, 2020
    Inventors: Dominique Amans, Stephen John Atkinson, Lee Andrew Harrison, David Jonathan Hirst, Robert Peter Law, Matthew Lindon, Alexander Preston, Jonathan Thomas Seal, Christopher Roland Wellaway
  • Benzo[b]furans as bromodomain inhibitors
    Patent number: 10583112
    Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.
    Type: Grant
    Filed: April 5, 2017
    Date of Patent: March 10, 2020
    Assignee: GlaxoSmithKline Intellectual Property (No. 2) Limited
    Inventors: Stephen John Atkinson, Emmanuel Hubert Demont, Lee Andrew Harrison, Alexander G. Preston, Jonathan Thomas Seal, Ian David Wall, Robert J. Watson, James Michael Woolven
  • PYRIDYL DERIVATIVES AS BROMODOMAIN INHIBITORS
    Publication number: 20200009140
    Abstract: The present invention is directed to pyridyl derivatives which are bromodomain inhibitors, pharmaceutical compositions comprising the compounds and the use of the compounds or the compositions in the treatment of various diseases or conditions
    Type: Application
    Filed: February 27, 2018
    Publication date: January 9, 2020
    Inventors: Stephen John ATKINSON, Emmanuel Hubert DEMONT, Lee Andrew HARRISON, Etienne LEVERNIER, Alexander G. PRESTON, Jonathan Thomas SEAL, Ian David WALL, Robert J. WATSON, James Michael WOOLVEN
  • PYRAZOLE DERIVATIVES AS BROMODOMAIN INHIBITORS
    Publication number: 20190381010
    Abstract: The present invention is directed to pyrazole derivatives, pharmaceutical compositions comprising the compounds and the use of the compounds or the compositions in the treatment of various diseases.
    Type: Application
    Filed: February 27, 2018
    Publication date: December 19, 2019
    Inventors: Stephen John ATKINSON, Emmanuel Hubert DEMONT, Lee Andrew HARRISON, Gemma Michele LIWICKI, Simon Christopher Cranko LUCAS, Alexander G. PRESTON, Jonathan Thomas SEAL, Ian David WALL, Robert J. WATSON
  • PYRIDINONE DICARBOXAMIDE FOR USE AS BROMODOMAIN INHIBITORS
    Publication number: 20190359572
    Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy
    Type: Application
    Filed: August 8, 2019
    Publication date: November 28, 2019
    Inventors: Stephen John ATKINSON, Helen Elizabeth AYLOTT, Anthony William James COOPER, Emmanuel Hubert DEMONT, Lee Andrew HARRISON, Thomas George Christopher HAYHOW, Matthew J. LINDON, Alexander G. PRESTON, Jonathan Thomas SEAL, Ian David WALL, Robert J. WATSON, James Michael WOOLVEN
  • 2-OXO-1,2-dihydropyridine-3,5-dicarboxamide compounds as bromodomain inhibitors
    Patent number: 10471050
    Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.
    Type: Grant
    Filed: October 3, 2016
    Date of Patent: November 12, 2019
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    Inventors: Stephen John Atkinson, Emmanuel Hubert Demont, Lee Andrew Harrison, Thomas George Christopher Hayhow, Matthew J. Lindon, Alexander G. Preston, Jonathan Thomas Seal, Ian David Wall, Robert J. Watson, James Michael Woolven
  • APPARATUSES, SYSTEMS, AND METHODS FOR REPRESENTING USER INTERACTIONS WITH REAL-WORLD INPUT DEVICES IN A VIRTUAL SPACE
    Publication number: 20190332184
    Abstract: A key assembly for a keyboard may include a key cap that includes a touch sensor that is communicatively coupled to a control device. When the touch sensor senses a touch event, the touch sensor may send a touch signal to the control device, and when the touch sensor senses an absence of touch, the touch sensor may send a control signal to the control device. The key assembly may further include a switch that is communicatively coupled to the control device and that is movable between a pressed position and an un-pressed position. When the switch is in the pressed position, the switch may send a closed signal to the control device, and when the switch is in the un-pressed position, the switch may send an open signal to the control device. Various other apparatuses, systems, and methods are also disclosed.
    Type: Application
    Filed: July 10, 2019
    Publication date: October 31, 2019
    Inventors: Andrew Harrison Imm, Grantland Lee Lim Chew
  • Pyridinone dicarboxamide for use as bromodomain inhibitors
    Patent number: 10428026
    Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy
    Type: Grant
    Filed: August 31, 2016
    Date of Patent: October 1, 2019
    Assignee: GlaxoSmithKline Intellectual Property (No.2) Limited
    Inventors: Stephen John Atkinson, Helen Elizabeth Aylott, Anthony William James Cooper, Emmanuel Hubert Demont, Lee Andrew Harrison, Thomas George Christopher Hayhow, Matthew J. Lindon, Alexander G. Preston, Jonathan Thomas Seal, Ian David Wall, Robert J. Watson, James Michael Woolven
  • Apparatuses, systems, and methods for representing user interactions with real-world input devices in a virtual space
    Patent number: 10394342
    Abstract: A key assembly for a keyboard may include a key cap that includes a touch sensor that is communicatively coupled to a control device. When the touch sensor senses a touch event, the touch sensor may send a touch signal to the control device, and when the touch sensor senses an absence of touch, the touch sensor may send a control signal to the control device. The key assembly may further include a switch that is communicatively coupled to the control device and that is movable between a pressed position and an un-pressed position. When the switch is in the pressed position, the switch may send a closed signal to the control device, and when the switch is in the un-pressed position, the switch may send an open signal to the control device. Various other apparatuses, systems, and methods are also disclosed.
    Type: Grant
    Filed: September 27, 2017
    Date of Patent: August 27, 2019
    Assignee: Facebook Technologies, LLC
    Inventors: Andrew Harrison Imm, Grantland Lee Lim Chew
  • Pyridinone dicarboxamide for use as bromodomain inhibitors
    Patent number: 10370356
    Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy
    Type: Grant
    Filed: September 20, 2016
    Date of Patent: August 6, 2019
    Assignee: GlaxoSmithKline Intellectual Property (No. 2) Limited
    Inventors: Stephen John Atkinson, Emmanuel Hubert Demont, Lee Andrew Harrison, Thomas George Christopher Hayhow, David House, Matthew J. Lindon, Alexander G. Preston, Jonathan Thomas Seal, Ian David Wall, Robert J. Watson, James Michael Woolven
  • PYRIDINE DICARBOXAMIDE DERIVATIVES AS BROMODOMAIN INHIBITORS
    Publication number: 20190202786
    Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.
    Type: Application
    Filed: May 22, 2017
    Publication date: July 4, 2019
    Inventors: Stephen John ATKINSON, Emmanuel Hubert DEMONT, Lee Andrew HARRISON, Etienne LEVERNIER, Alexander G. PRESTON, Jonathan Thomas SEAL, Ian David WALL, Robert J. WATSON, James Michael WOOLVEN